Citation: | YIN Jiansong, WAN Yu, ZHANG Liwen, MA Liang, XUE Fei, ZHOU Chengyu, LENG Kaiqiang, HUANG Zhiying. Analysis of related factors of mycoplasma pneumoniae pneumonia complicated with pleural effusion[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 54-58. DOI: 10.7619/jcmp.20210049 |
[1] |
KUTTY P K, JAIN S, TAYLOR T H, et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia[J]. Clin Infect Dis, 2019, 68(1): 5-12. http://europepmc.org/abstract/MED/29788037
|
[2] |
KUMAR S. Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections[J]. Indian J Med Res, 2018, 147(1): 23-31. doi: 10.4103/ijmr.IJMR_1582_16
|
[3] |
KIM J H, KWON J H, LEE J Y, et al. Clinical features of Mycoplasma pneumoniae coinfection and need for its testing in influenza pneumonia patients[J]. J Thorac Dis, 2018, 10(11): 6118-6127. doi: 10.21037/jtd.2018.10.33
|
[4] |
中华医学会儿科学分会呼吸学组, 《中华实用儿科临床杂志》编辑委员会. 儿童肺炎支原体肺炎诊治专家共识(2015年版)[J]. 中华实用儿科临床杂志, 2015, 30(17): 1304-1308. doi: 10.3760/cma.j.issn.2095-428X.2015.17.006
|
[5] |
MEYER SAUTEUR P M, VAN ROSSUM A M, VINK C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance[J]. Curr Opin Infect Dis, 2014, 27(3): 220-227. doi: 10.1097/QCO.0000000000000063
|
[6] |
李丽萍, 孙伟, 王瑞涛. CRP、PCT和IL-8对治疗儿童肺炎支原体肺炎并发胸腔积液的指导价值[J]. 中国医学前沿杂志: 电子版, 2019, 11(8): 46-49. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201908008.htm
|
[7] |
王冠玲, 胡斌飞. 肺炎支原体肺炎住院儿童合并胸腔积液的危险因素分析[J]. 医学研究杂志, 2017, 46(2): 142-144, 161. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ201702042.htm
|
[8] |
王建, 丁圣刚, 侯舒, 等. 不同年龄阶段儿童的难治性肺炎支原体肺炎临床特点[J]. 临床肺科杂志, 2019, 24(9): 1614-1617. doi: 10.3969/j.issn.1009-6663.2019.09.015
|
[9] |
国家卫生计生委合理用药专家委员会儿童用药专业组. 中国儿童肺炎支原体感染实验室诊断规范和临床实践专家共识(2019年)[J]. 中华儿科杂志, 2020, 58(5): 366-373.
|
[10] |
HE J, LIU M, YE Z, et al. Insights into the pathogenesis of Mycoplasma pneumoniae (Review)[J]. Mol Med Rep, 2016, 14(5): 4030-4036. doi: 10.3892/mmr.2016.5765
|
[11] |
JIN J, WANG J, LU Y, et al. Platelet-derived microparticles: a new index of monitoring platelet activation and inflammation in Kawasaki disease[J]. Indian J Pediatr, 2019, 86(3): 250-255. doi: 10.1007/s12098-018-2765-2
|
[12] |
KRZEMIEÑG, PAÑCZYK-TOMASZEWSKA M, ADAMCZUK D, et al. Neutrophil gelatinase-associated lipocalin: a biomarker for early diagnosis of urinary tract infections in infants[J]. Adv Exp Med Biol, 2018, 1047: 71-80. http://www.ncbi.nlm.nih.gov/pubmed/28980274
|
[13] |
ARINGER M. Inflammatory markers in systemic lupus erythematosus[J]. J Autoimmun, 2020, 110: 102374. doi: 10.1016/j.jaut.2019.102374
|
[14] |
王全, 蒋健飞, 赵德育. 肺炎支原体肺炎发生肺外并发症的危险因素[J]. 中华实用儿科临床杂志, 2013, 28(10): 749-751. doi: 10.3760/cma.j.issn.2095-428X.2013.10.009
|
[15] |
CORSONELLO A, PEDONE C, BATTAGLIA S, et al. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD)[J]. Arch Gerontol Geriatr, 2011, 53(2): 190-195. doi: 10.1016/j.archger.2010.10.015
|
[16] |
ARQUES S. Human serum albumin in cardiovascular diseases[J]. Eur J Intern Med, 2018, 52: 8-12. doi: 10.1016/j.ejim.2018.04.014
|
[17] |
AMDUR R L, FELDMAN H I, DOMINIC E A, et al. Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study[J]. Am J Kidney Dis, 2019, 73(3): 344-353. doi: 10.1053/j.ajkd.2018.09.012
|
[18] |
LIN Y, TAN D, KAN Q N, et al. The protective effect of naringenin on airway remodeling after Mycoplasma pneumoniae infection by inhibiting autophagy-mediated lung inflammation and fibrosis[J]. Mediators Inflamm, 2018, 2018: 8753894. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904783/
|